#drug-pricing
(6 articles)Trump Tariffs on Generic Drug Makers Threaten Supply Chain
President Trump has announced plans to impose new tariffs on generic drug manufacturers, with implementation scheduled for two years hence. This policy proposal represents a significant shift in pharm
Trump's 200% Generic Drug Tariffs Threaten Pharma Supply Chains
The Trump administration's proposal to impose 200% tariffs on generic pharmaceuticals represents a structural shift in pharmaceutical trade policy with far-reaching supply chain consequences. The anno
US Launches Section 301 Probe Into German Drug Pricing
The U.S. Trade Representative has initiated a Section 301 investigation into Germany's drug pricing policies, alleging that the European nation's regulatory framework unfairly shifts pharmaceutical re
Tariffs and Geopolitics Reshape Pharma Supply Chains
The pharmaceutical industry faces unprecedented pressure as tariff escalations and geopolitical fragmentation fundamentally alter how companies source ingredients, manufacture drugs, and distribute pr
US Tariffs on Pharma Threaten Drug Costs and Global Supply
US tariff policies targeting pharmaceutical imports present a critical structural challenge to global drug supply chains and patient access. The pharmaceutical industry relies heavily on cross-border
Trump's Drug Tariffs Force Pharma Supply Chain Rethink
The Trump administration's proposed tariffs on pharmaceuticals represent a structural shift in how the industry sources active pharmaceutical ingredients and finished drugs, potentially forcing manufa